The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Financial toxicity and association with treatment outcomes during pediatric CAR T therapy.
 
Daniel Zheng
No Relationships to Disclose
 
Lei Wang
No Relationships to Disclose
 
Kelly Getz
No Relationships to Disclose
 
Richard Aplenc
No Relationships to Disclose
 
Kerry Coughlin
No Relationships to Disclose
 
Amanda DiNofia
No Relationships to Disclose
 
Shannon Maude
Consulting or Advisory Role - Novartis; WUGEN, Inc.
Research Funding - Novartis (Inst); WUGEN, Inc. (Inst)
Patents, Royalties, Other Intellectual Property - PCT/US2017/044425: Combination Therapies of Car and PD-1 Inhibitors
 
Regina Myers
No Relationships to Disclose
 
Haley Newman
No Relationships to Disclose
 
Taylor Orsini
Employment - Children's Hospital of Philadelphia
Research Funding - Marinus Pharmaceuticals (Inst)
 
Donnette Paris
Employment - CHOP; Highmark (I)
Research Funding - The Children's Hospital of Philadelphia
 
Stephan Grupp
Consulting or Advisory Role - Alimera Sciences; BiolineRx; Cabaletta Bio; Estrella; Jazz Pharmaceuticals; Novartis; Verismo; Vertex
Speakers' Bureau - Adaptive Biotechnologies
Research Funding - Kite/Gilead (Inst); Novartis (Inst); SERVIER (Inst); Vertex (Inst)
Patents, Royalties, Other Intellectual Property - UPenn Toxicity management patent (Inst)
 
Allison Barz Leahy
No Relationships to Disclose